Humana Inc. (HUM)
NYSE: HUM · Real-Time Price · USD
192.20
+0.13 (0.07%)
Feb 5, 2026, 11:21 AM EST - Market open
Humana Stock Forecast
Stock Price Forecast
The 17 analysts that cover Humana stock have a consensus rating of "Hold" and an average price target of $285.18, which forecasts a 48.38% increase in the stock price over the next year. The lowest target is $174 and the highest is $345.
Price Target: $285.18 (+48.38%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Humana stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Buy | 5 | 5 | 5 | 5 | 4 | 4 |
| Hold | 17 | 12 | 11 | 11 | 12 | 11 |
| Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 23 | 18 | 17 | 18 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold → Sell Downgrades $262 → $174 | Hold → Sell | Downgrades | $262 → $174 | -9.47% | Feb 2, 2026 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $290 | Buy → Hold | Downgrades | $290 | +50.88% | Jan 7, 2026 |
| Barclays | Barclays | Hold Maintains $234 → $245 | Hold | Maintains | $234 → $245 | +27.47% | Jan 5, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $277 → $262 | Hold | Maintains | $277 → $262 | +36.32% | Dec 18, 2025 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $253 → $313 | Hold → Strong Buy | Upgrades | $253 → $313 | +62.85% | Dec 5, 2025 |
Financial Forecast
Revenue This Year
130.53B
from 117.76B
Increased by 10.84%
Revenue Next Year
146.49B
from 130.53B
Increased by 12.23%
EPS This Year
17.25
from 9.98
Increased by 72.84%
EPS Next Year
12.16
from 17.25
Decreased by -29.52%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 136.2B | 172.1B | ||||
| Avg | 130.5B | 146.5B | ||||
| Low | 126.2B | 134.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 15.6% | 31.9% | ||||
| Avg | 10.8% | 12.2% | ||||
| Low | 7.2% | 3.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 18.52 | 15.13 | ||||
| Avg | 17.25 | 12.16 | ||||
| Low | 16.38 | 8.07 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 85.6% | -12.3% | ||||
| Avg | 72.8% | -29.5% | ||||
| Low | 64.1% | -53.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.